Susquehanna International Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-7,600
Closed -$504K – 12727
2024
Q1
$504K Buy
+7,600
New +$469K ﹤0.01% 8501
2022
Q3
– Sell
-10,500
Closed -$478K – 13731
2022
Q2
$478K Buy
+10,500
New +$470K ﹤0.01% 8375
2021
Q4
– Sell
-4,900
Closed -$260K – 13548
2021
Q3
$260K Buy
+4,900
New +$276K ﹤0.01% 10925

Other funds holding LMAT

Susquehanna International Group's LMAT Position: Q2 2026 in Review

Susquehanna International Group sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 9,694 shares — an estimated $1.06M sold.

Susquehanna International Group first reported a position in LMAT in Q4 2016 and held it in 15 quarters. The position peaked at $2.17M in Q2 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Susquehanna International Group reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 9,694 LeMaitre Vascular shares in Q2 2026, an estimated $1.06M.
  • Susquehanna International Group first reported a position in LeMaitre Vascular in Q4 2016 and held it in 15 quarters.
  • Susquehanna International Group's LeMaitre Vascular position peaked at $2.17M in Q2 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.